THIOTEPA, BUSULFAN, AND CYCLOPHOSPHAMIDE - A NEW PREPARATIVE REGIMEN FOR AUTOLOGOUS MARROW OR BLOOD STEM-CELL TRANSPLANTATION IN HIGH-RISK MULTIPLE-MYELOMA

被引：1
|
作者：
DIMOPOULOS, MA [1 ]
ALEXANIAN, R [1 ]
PRZEPIORKA, D [1 ]
HESTER, J [1 ]
ANDERSSON, B [1 ]
GIRALT, S [1 ]
MEHRA, R [1 ]
VANBESIEN, K [1 ]
DELASALLE, KB [1 ]
READING, C [1 ]
DEISSEROTH, AB [1 ]
CHAMPLIN, RE [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT HEMATOL,BONE MARROW TRANSPLANTAT SECT,HOUSTON,TX 77030
来源：
BLOOD | 1993年 / 82卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2324 / 2328
页数：5
相关论文
共 50 条
  • [1] AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION IN HIGH-RISK MULTIPLE-MYELOMA
    REIFFERS, J
    MARIT, G
    BOIRON, JM
    BRITISH JOURNAL OF HAEMATOLOGY, 1989, 72 (02) : 296 - 297
  • [2] BUSULFAN AND MELPHALAN AS CONDITIONING REGIMEN FOR AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA
    ALEGRE, A
    LAMANA, M
    ARRANZ, R
    FERNANDEZVILLALTA, MJ
    TOMAS, JF
    FIGUERA, A
    CAMARA, R
    STEEGMAN, JL
    CASADO, F
    REQUENA, MJ
    PLANAS, JL
    VAZQUEZ, L
    GRANDA, A
    FERNANDEZRANADA, JM
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (02) : 380 - 386
  • [3] Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma
    Song, Ga-Young
    Jung, Sung-Hoon
    Kim, Mihee
    Ahn, Seo-Yeon
    Ahn, Jae-Sook
    Yang, Deok-Hwan
    Kim, Hyeong-Joon
    Kim, Jin Seok
    Eom, Hyeon-Seok
    Moon, Joon Ho
    Yhim, Ho-Young
    Kim, Kihyun
    Min, Chang-Ki
    Lee, Je-Jung
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S157 - S158
  • [4] Busulfan and thiotepa conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma
    Jung, Sung-Hoon
    Ahn, Seo-Yeon
    Yang, Deok-Hwan
    Kim, Hyeoung-Joon
    Kim, Jin Seok
    Kim, Kihyun
    Eom, Hyeon-Seok
    Yhim, Ho-Young
    Lee, Yoo Jin
    Hyun, Shin Young
    Lee, Je-Jung
    BONE MARROW TRANSPLANTATION, 2019, 54 : 226 - 226
  • [5] AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION IN HIGH-RISK MYELOMA
    MARIT, G
    BOIRON, JM
    REIFFERS, J
    BONE MARROW TRANSPLANTATION, 1990, 5 : 55 - 55
  • [6] BUSULFAN AND CYCLOPHOSPHAMIDE HAS SIMILAR OUTCOMES TO HIGH DOSE MELPHALAN AS A PREPARATIVE REGIMEN FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA
    Mahindra, A.
    Bolwell, B.
    Rybicki, L.
    Dean, R.
    Poblman, B.
    Sobecks, R.
    Andresen, S.
    Sweetenbam, J.
    Kalaycio, M.
    Copelan, E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 69 - 69
  • [7] BLOOD STEM-CELL AUTOGRAFTS IN PATIENTS WITH HIGH-RISK MULTIPLE-MYELOMA
    DEROSA, L
    MONTUORO, A
    ZOLI, V
    LANTI, T
    COSSUTTA, M
    DELAURENZI, A
    BONE MARROW TRANSPLANTATION, 1990, 5 : 58 - 59
  • [8] Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma
    Shimoni, A
    Smith, TL
    Aleman, A
    Weber, D
    Dimopoulos, M
    Anderlini, P
    Andersson, B
    Claxton, D
    Ueno, NT
    Khouri, I
    Donato, M
    Korbling, M
    Alexanian, R
    Champlin, R
    Giralt, S
    BONE MARROW TRANSPLANTATION, 2001, 27 (08) : 821 - 828
  • [9] Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma
    A Shimoni
    TL Smith
    A Aleman
    D Weber
    M Dimopoulos
    P Anderlini
    B Andersson
    D Claxton
    NT Ueno
    I Khouri
    M Donato
    M Korbling
    R Alexanian
    R Champlin
    S Giralt
    Bone Marrow Transplantation, 2001, 27 : 821 - 828
  • [10] HIGH-DOSE CHEMORADIOTHERAPY AND AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA
    FERMAND, JP
    CHEVRET, S
    HENNEQUIN, C
    LEVY, Y
    GEROTA, J
    BENBUNAN, M
    SELIGMANN, M
    BROUET, JC
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1991, 33 (06): : 525 - 528
12345